^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

universal chimeric antigen receptor-modified AT19 cells

i
Other names: universal chimeric antigen receptor-modified AT19 cells, CAR-NK-CD19 cells, AT19 cells
Associations
Trials
Company:
Chengdu USino Techno, Wuhan Union Hospital
Drug class:
CD19 inhibitor
Associations
Trials